At the news
? NEUTRALIMPACT 2/10 SC 13G/A filed Nov 6, 2026 at 16:05 ET
Opaleye Management Inc. and related entities filed an amendment to Schedule 13G disclosing a 3.76% passive stake (1,120,000 shares) in Q32 Bio Inc. as of September 30, 2026. This is a decrease from the prior filing by Point72 Asset Management (which held shares as of August 2026), indicating Opaleye's position is new and below the 5% threshold. The filing is routine and does not signal activist intent.
- Opaleye Management Inc., Opaleye L.P., and James Silverman filed an amendment to Schedule 13G.
- The group beneficially owns 1,120,000 shares of Q32 Bio common stock.
- The stake represents 3.76% of shares outstanding, based on 29,769,466 shares as of August 3, 2026.
- The filing is passive under Rule 13d-1(c) with no control intent.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access